Contributing Member of the Legal, Economic & Regulatory Affairs Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Obama's Proposed Health Insurance Rate Authority Nibbling Around the Edges

February 23, 2010

Analysis of:UnitedHealth, WellPoint get tax delay in Obama plan | www.finance-commerce.com

Obama's health care reform proposal give insurers most of what they bargained for and is unlikely to have a large impact on future earnings. The inclusion of an individual mandate still means 30 million new customers, even if medical cost management tools are restricted by future legislation

Biopharma - Skating to Where the Puck is Going to Be

July 15, 2009

Analysis of:The Pharmaceutical Industry Gives the Obama Health Care Initiative $80 Billion and Can Come Out with a Bigger Prize?? | pharmservices.blogspot.com

Promising cost-savings before they are forcibly removed from your business can be an effective strategy. The commitment from biopharma manufacturers could enable products developed in the future to be priced more favorably than if government controls are put in place across the board. Anticipating pharma's next move, how generic manufacturers will react and what Congress is likely to do with the promise is essential for investors.

Page : 11 to 2 of 2

Subscribe to Updates

By RSS